Stockreport

Benitec inks gene therapy development deal with Axovant Sciences valued at up to $187.5M [Seeking Alpha]

Benitec Biopharma Inc.  (BNTC) 
US:NASDAQ Investor Relations: benitec.com/for-investors/investor-faqs
PDF Benitec inks gene therapy development deal with Axovant Sciences valued at up to $187.5M [Read more]